Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer, Endometrial Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07318415
What this trial is testing

Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00022620
What this trial is testing

Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Active Not RecruitingNCT04008797
What this trial is testing

E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Who this might be right for
Endometrial NeoplasmsNeoplasmsCarcinoma, Hepatocellular+2 more
Eisai Inc. 301
Early research (Phase 1)Looking for participantsNCT06974110
What this trial is testing

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorEndometrial Cancer+4 more
MOMA Therapeutics 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT04956640
What this trial is testing

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal NeoplasmsEndometrial Neoplasms+3 more
Eli Lilly and Company 540
Not applicableUnknownNCT04577950
What this trial is testing

A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Centre Hospitalier Universitaire Vaudois 120
Not applicableLooking for participantsNCT06268626
What this trial is testing

Detection of Endometrial Cancer Through Risk Modelling

Who this might be right for
Endometrial Cancer
University of British Columbia 1,000
Testing effectiveness (Phase 2)Study completedNCT01523678
What this trial is testing

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Who this might be right for
Ovarian CancerEndometrial CancerUterine Cervical Cancer
Belgian Gynaecological Oncology Group 108
Not applicableUnknownNCT06273878
What this trial is testing

From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy

Who this might be right for
Endometrial Cancer
Regina Elena Cancer Institute 80
Not applicableUnknownNCT02296307
What this trial is testing

DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

Who this might be right for
Ovarian Neoplasms
McGill University 13,600
Early research (Phase 1)Looking for participantsNCT06795009
What this trial is testing

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Who this might be right for
Uterine CancerEndometrial Cancer
Washington University School of Medicine 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT05489848
What this trial is testing

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

Who this might be right for
Endometrial Cancer
Fudan University 294
Early research (Phase 1)Study completedNCT00408655
What this trial is testing

Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerRecurrent Endometrial Carcinoma+9 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT00723255
What this trial is testing

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Carcinoma
National Cancer Institute (NCI) 53
Not applicableStudy completedNCT00755651
What this trial is testing

Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy

Who this might be right for
Abnormal Uterine Bleeding
Royal Free Hampstead NHS Trust 180
Not applicableUnknownNCT05738902
What this trial is testing

Adherence and Compliance to ERAS in Gynecological Surgery

Who this might be right for
ERASGynecologic CancerPost Operative Pain+5 more
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 600
Not applicableNot Yet RecruitingNCT07739745
What this trial is testing

Development Of An Endometrial Cancer Educational Tool

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 250
Early research (Phase 1)Looking for participantsNCT07318324
What this trial is testing

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

Who this might be right for
Phase IBAvutometinibRAS Pathway+1 more
M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897527
What this trial is testing

Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100
Next Page